NUKINA Trademark

Trademark Overview


On Thursday, August 2, 2001, a trademark application was filed for NUKINA with the United States Patent and Trademark Office. The USPTO has given the NUKINA trademark a serial number of 76294812. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, May 9, 2003. This trademark is owned by Pfizer Inc.. The NUKINA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; pharmaceutical preparations, namely, pharmaceutical preparation for the treatment of anxiety, depression, pain, gastrointestinal disorders, neuropsychiatric disorders including both psychotic and non-psychotic conditions, neurodegenerative disorders; and substance abuse disorders, including both abuse and dependence

General Information


Serial Number76294812
Word MarkNUKINA
Filing DateThursday, August 2, 2001
Status601 - ABANDONED - EXPRESS
Status DateFriday, May 9, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 27, 2001

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; pharmaceutical preparations, namely, pharmaceutical preparation for the treatment of anxiety, depression, pain, gastrointestinal disorders, neuropsychiatric disorders including both psychotic and non-psychotic conditions, neurodegenerative disorders; and substance abuse disorders, including both abuse and dependence

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 17, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, May 9, 2003ABANDONMENT - EXPRESS MAILED
Friday, May 9, 2003PAPER RECEIVED
Wednesday, August 14, 2002EXTENSION 1 GRANTED
Thursday, August 8, 2002EXTENSION 1 FILED
Thursday, August 8, 2002TEAS EXTENSION RECEIVED
Tuesday, February 19, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 27, 2001PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2001NOTICE OF PUBLICATION
Tuesday, October 2, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 12, 2001ASSIGNED TO EXAMINER